3年间隔对HPV检测阴性女性再筛查过短:一项基于人群的队列研究
该基于人群的队列研究比较了意大利两个HPV筛查项目中女性初次HPV检测阴性后3年再筛查的结果,发现再筛查时HPV阳性率、阴道镜转诊率、CIN2+检出率和阴道镜对CIN2+的阳性预测值均显著降低,结论认为HPV阴性后3年再筛查间隔过短。
要点
- 再筛查时HPV阳性率较初次筛查显著降低(RR 0.55,95% CI 0.51-0.60)。
- 再筛查时CIN2+检出率显著低于初次筛查(RR 0.24,95% CI 0.13-0.39)。
- 阴道镜对CIN2+的阳性预测值在再筛查时显著降低(RR 0.51,95% CI 0.29-0.87)。
核心结论
- HPV检测阴性后3年再筛查时疾病频率极低且阴道镜阳性预测值不足,表明3年间隔过短。
研究设计与样本
- 基于人群的队列研究,纳入2009年4月至2015年10月受邀筛查的25-64岁女性,初次筛查48751人,3年后再筛查22000人。
主要发现
- 再筛查应答率略高于初次筛查(74.5% vs 72.1%;转诊率RR 1.11,95% CI 1.07-1.14)。
- 再筛查HPV阳性率显著低于初次筛查(RR 0.55,95% CI 0.51-0.60)。
- 再筛查阴道镜转诊率显著低于初次筛查(RR 0.47,95% CI 0.41-0.53)。
- 再筛查CIN2+检出率显著低于初次筛查(RR 0.24,95% CI 0.13-0.39)。
- 再筛查阴道镜对CIN2+的阳性预测值显著低于初次筛查(RR 0.51,95% CI 0.29-0.87)。
关键数值与推荐
- HPV检测采用Hybrid Capture 2法,HPV阳性样本行细胞学分流,异常者立即阴道镜,细胞学阴性者1年后复查HPV。
临床怎么用
- 作者认为HPV检测阴性后3年再筛查间隔过短,再筛查效率低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the results from an initial negative human papillomavirus (HPV) test with re-screening after 3 years in women attending two HPV-based screening programmes. DESIGN: Population-based cohort study. SETTING: Two cervical service screening programmes in Italy. POPULATION: Women aged 25-64 years invited to screening from April 2009 to October 2015. METHODS: Eligible women were invited to undergo an HPV test. Those with a negative HPV test went on to the next screening round 3 years later. Cytology triage was performed for HPV+ (HPV by Hybrid Capture 2) samples, with immediate colposcopy (if abnormal) and HPV re-testing 1 year later (if negative). MAIN OUTCOME MEASURES: Participation rate, positivity at HPV and at triage, referral rate to colposcopy, positive predictive value for cervical intraepithelial neoplasia grade 2+ (CIN2+) at colposcopy, and detection rate for CIN2+. RESULTS: We present the results from 48 751 women at the first screening and 22 000 women at re-screening 3 years later. The response rate was slightly higher at the second screening (74.5 versus 72.1% at the first screening; referral rate, RR 1.11; 95% confidence interval, 95% CI, 1.07-1.14). Compared with the first screening, we observed a significant reduction at the second screening in terms of HPV positivity (RR 0.55, 95% CI 0.51-0.60), referral rate to colposcopy (RR 0.47, 95% CI 0.41-0.53), CIN2+ detection rate (RR 0.24, 95% CI 0.13-0.39), and positive predictive value (PPV) for CIN2+ at colposcopy (RR 0.51, 95% CI 0.29-0.87). CONCLUSIONS: The very low frequency of disease and inadequate PPV at colposcopy indicate that a 3-year interval after a negative HPV test is too short. TWEETABLE ABSTRACT: Three years after a negative HPV the frequency of cervical disease is so low that re-screening is inefficient.
引用
- Zorzi M, Frayle H, Rizzi M, et al. A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study. BJOG. 2017. PMID: 28120382. doi:10.1111/1471-0528.14575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。